Vaccines

Moderna isn’t an RNA platform company—it’s a pandemic procurement vehicle that hasn’t yet proven its tech works beyond emergency use.

The world’s largest vaccine maker by volume is not a tech disruptor — it’s a high-volume, low-margin public health utility run as a private company.

A state-owned vaccine developer that delivered peer-reviewed efficacy — and sold 400,520 faulty doses.

In 2004, Sanofi didn’t innovate—it absorbed.